Dementia care isn't just about new drugs, said the author of a cost-effectiveness study comparing collaborative care, Leqembi ...
A new study finds THC, when combined with an anti-inflammatory drug, improved memory and reduced Alzheimer’s-related brain damage in mice, raising hope for future treatment.
While still in an early stage, interest in testing asymptomatic patients is growing as drug developers explore treating ...
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
The firm provided updates alongside Q4 and full-year 2025 financial results, and reported $19.29 billion and $65.18 billion ...
Scientists say combining a low-dose of THC with a common anti-inflammatory drug improved cognition and reduced ...
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 1 ...
Axon Neuroscience’s active tau immunotherapy, AADvac1, has been selected as the first tau-targeted therapy to enter a ...
Panelists discuss how advanced practice providers (APPs) play a central role in identifying and managing amyloid-related ...
A new study suggests low doses of THC, the main psychoactive ingredient in cannabis, may protect memory and reduce brain ...
New research suggests THC’s cognitive drawbacks may be mitigated when combined with a targeted anti-inflammatory drug. Cannabis research has highlighted a scientific paradox. Its best-known ...
Some people don’t develop dementia despite showing signs of Alzheimer’s disease in their brain, and we're starting to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results